NCCN Guidelines for Patients® | Ovarian Cancer - page 63

63
Part 7: Recurrence treatment
NCCN Guidelines for Patients
®
: Ovarian cancer
Version 1.2013
Par t 1
Par t 2
Par t 3
Par t 4
Par t 5
Par t 6
Par t 7
Par t 8
Par t 9
Par t 10
Definitions:
CA-125:
A protein that is
made by ovarian cancer
cells as well as normal cells
Hot flashes:
A feeling of
intense heat and body
sweat for short periods
Imaging test:
A test that
makes pictures (images) of
the inside of the body
Indigestion:
Feeling of
discomfort, such as heat,
burning, or pain in the
upper belly area
Libido:
Sexual desire or
emotions related to sex
Side effect:
An unplanned
physical or emotional
response to treatment
Recommendations for recurrence
The treatment recommendations for ovarian cancer that comes back—called a
recurrence or relapse—are based on the type of relapse. A biochemical relapse
is when blood tests show an increase in CA-125 levels, but you don’t have
symptoms and there are no signs of recurrence on the imaging tests or physical
exam. A radiographic relapse is when imaging tests show signs that the cancer
has come back. A clinical relapse is when you have physical signs or symptoms
that ovarian cancer has come back. Physical signs of recurrence include
abdominal bloating and sudden weight changes. Symptoms of recurrence may
include pelvic or abdominal pain, indigestion or constipation, difficulty eating or
feeling full quickly, or needing to urinate frequently or urgently.
Acronyms:
CA-125 =
Cancer antigen
125
1...,53,54,55,56,57,58,59,60,61,62 64,65,66,67,68,69,70,71,72,73,...100
Powered by FlippingBook